INOVIO PHARMACEUTICALS, INC. Accounts Receivable, Related Parties, Current
INOVIO PHARMACEUTICALS, INC. (INO) had Accounts Receivable, Related Parties, Current of $4.96 million as of 2023-03-31, per its 10-Q filed 2023-05-10.
Discontinued › Notes
us-gaap:AccountsReceivableRelatedPartiesCurrent · last filed 2023-05-10
- 2023-03-31: Accounts Receivable, Related Parties, Current $4.96M.
- 2022-12-31: Accounts Receivable, Related Parties, Current $10.04M.
- 2022-09-30: Accounts Receivable, Related Parties, Current $7.64M.
- 2022-06-30: Accounts Receivable, Related Parties, Current $6.89M.
| Period end | Accounts Receivable, Related Parties, Current |
|---|---|
| 2023-03-31 | $4.96M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $10.04M 10-Q · filed 2023-05-10 |
| 2022-09-30 | $7.64M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.89M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.49M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $2.57M 10-K · filed 2023-03-01 |
| 2021-09-30 | $2.35M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $722.94K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $346.97K 10-Q · filed 2021-05-10 |
| 2020-12-31 | $503.78K 10-K · filed 2022-03-01 |
| 2020-09-30 | $501.31K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $482.37K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $634.20K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.33M 10-K · filed 2021-03-01 |
| 2019-09-30 | $978.54K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $996.94K 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.30M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $738.58K 10-K · filed 2020-03-12 |
| 2018-09-30 | $1.57M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $960.45K 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.24M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $486.62K 10-K · filed 2019-03-12 |
| 2017-09-30 | $924.68K 10-Q · filed 2017-11-08 |
| 2017-06-30 | $1.19M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $1.23M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $748.36K 10-K · filed 2018-03-14 |
| 2015-12-31 | $33.45K 10-K · filed 2017-03-15 |
| 2014-03-31 | $18.65K 10-Q · filed 2014-05-12 |
| 2013-12-31 | $0.00 10-Q · filed 2014-05-12 |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-12 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-09 |
| 2013-03-31 | $43.54K 10-Q · filed 2013-05-10 |
| 2012-12-31 | $36.23K 10-K · filed 2014-03-17 |
| 2011-12-31 | $38.41K 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |